COVID-19 Mortality Spikes in Patients with Lung, Blood Cance
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
New research from China suggests cancer patients are at greater risk of severe outcomes and death from COVID-19, specifically those with lung and hematologic malignancies, or late-stage disease.

In a multicenter study of over 600 COVID-19 patients, those with cancer had significantly higher risks for death, intensive care unit (ICU) admission, severe or critical symptoms, and invasive mechanical ventilation compared with age-matched controls.

According to the findings, 11.4% of the 105 cancer patients died versus roughly 5% of the non-cancer patients. The highest mortality rates were in patients with hematologic malignancies (33.3%), and those with lung (18.1%) and esophageal (16.7%) tumors.

And while those with early-stage cancers had outcomes similar to non-cancer controls, those with metastatic disease had the highest risks for severe outcomes from COVID-19:

-- Death
-- ICU admission
-- Severe symptoms
-- Invasive ventilation

Comorbidities as well as presence of disease within the lungs may play a role in the worse outcomes seen in lung cancer patients with COVID-19. However it's unclear whether cancer patients in general have any higher risk of infection from the COVID-19 coronavirus.

Source: https://www.medpagetoday.com/meetingcoverage/aacr/86201
Like
Comment
Share